Pyrimethamine
Malaria,Falciparum
Duke UniversitySmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Malaria,Falciparum cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PIPERAQUINOLINE Duke University | Phase 4 | BB |
FANSIDAR COMPONENT SULFADOXINE Duke University | Phase 4 | BB |
AMODIAQUINE Duke University | Phase 4 | BB |
Proguanil Duke University | Phase 4 | BB |
DIHYDROARTIMISININ Duke University | Phase 4 | BB |
Same molecule, other indications
Pyrimethamine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →